Newborn Screening Announcements
X-linked Adrenoleukodystrophy (X-ALD) has been approved for addition to Michigan's panel. The NBS Program is actively developing protocols for screening and follow-up so that screening can be initiated as soon as a Food and Drug Administration (FDA) laboratory assay is available. More details will be provided once a screening start date is determined.
Updated 10-16-2018 NBS Main Page